↓ Skip to main content

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Overview of attention for article published in European Journal of Clinical Pharmacology, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
114 Dimensions

Readers on

mendeley
84 Mendeley
Title
Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Published in
European Journal of Clinical Pharmacology, February 2015
DOI 10.1007/s00228-014-1801-z
Pubmed ID
Authors

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby, Connie T. Azumaya, Cheryl Wei, Yusong Chen, Rogelio Mosqueda-Garcia, Helen J. Ambrose

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Unknown 83 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 19%
Student > Master 13 15%
Student > Ph. D. Student 11 13%
Other 10 12%
Student > Bachelor 8 10%
Other 11 13%
Unknown 15 18%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 27 32%
Medicine and Dentistry 17 20%
Agricultural and Biological Sciences 9 11%
Biochemistry, Genetics and Molecular Biology 6 7%
Nursing and Health Professions 2 2%
Other 6 7%
Unknown 17 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2024.
All research outputs
#3,158,560
of 26,017,215 outputs
Outputs from European Journal of Clinical Pharmacology
#259
of 2,829 outputs
Outputs of similar age
#43,632
of 373,463 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#3
of 25 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,829 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 373,463 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.